Healthtech Startups

Fortuna modernizes the infrastructure and consumer experience for Medicaid and government health programs. The company focuses on improving enrollment, eligibility verification, and access to coverage for Medicaid, CHIP, and Marketplace beneficiaries.

2 investors

Foundation Health offers an AI operating system for pharmacies that automates prior authorizations, refill authorizations, financial assistance enrollment, 340B compliance, and patient communications, along with a white-labeled digital pharmacy front door and a healthcare API. It serves health systems, health plans/insurers, and developers, primarily in the US healthcare and pharmacy market.

2 investors

Fourier Health builds infrastructure to unlock unstructured clinical data from healthcare systems, enabling AI models and clinicians to access actionable intelligence from records currently locked in PDFs and fragmented systems. The company serves healthcare providers, researchers, and AI developers seeking trustworthy clinical data integration and analysis.

2 investors

Fovionics develops smart glasses for blind and visually impaired people, aimed at assisting with reading and daily tasks. The company focuses on making assistive vision technology affordable, with roots addressing accessibility gaps in Brazil.

2 investors

Francis Medical is a medical device company developing minimally invasive urological cancer treatments using water vapor ablation technology, initially focused on prostate cancer with its Vanquish Water Vapor Ablation System. It plans to expand into bladder and kidney cancer applications, aiming to reduce the side effects associated with conventional prostate treatments.

2 investors

Fraunhofer is a research organization whose Institute for Toxicology and Experimental Medicine (ITEM) conducts contract research, including cell-based in vitro inhalation methods to assess respiratory effects of aerosols and identify potentially harmful substances without animal testing. Its work supports safe product development under a safe-by-design approach.

2 investors

Free Market Health operates a care-driven marketplace platform for the specialty pharmacy ecosystem. The platform connects patients with specialty pharmacies and helps implement value-based care models for pharmacies, payers, and patients.

2 investors

Freed builds an AI assistant for clinicians that generates clinical notes from patient encounters, offering customizable templates, visit prep summaries, patient-friendly instructions, referral and other letters, and suggested billable ICD-10, CPT, and E/M codes that can sync to an EHR. It serves healthcare providers looking to reduce documentation time.

2 investors

Freedom One Life builds the Series 5, a premium electric powered wheelchair designed by a powerchair user for both everyday use and outdoor adventures, offering up to 60km range and hybrid indoor/outdoor capability. The company serves people with mobility needs and offers nationwide test drives in the UK.

2 investors

Friday Health Plans was a group of state-based health insurance companies operating in Colorado, Georgia, Nevada, North Carolina, Oklahoma, and Texas. The company is now in court-administered liquidation, with the page providing information for members and providers about the receivership process.

2 investors

Frontera Health develops AI technology for Applied Behavior Analysis (ABA) that helps BCBAs and clinics work more efficiently and treat more children diagnosed with autism. The tools aim to increase patient access, improve clinic operations, and support more precise treatment plans for children and their families in the United States.

2 investors

FUS Mobile develops the Neurolyser XR, a non-invasive medical device that uses high intensity focused ultrasound (HIFU) with fluoroscopic guidance to thermally ablate the lumbar medial branch nerve for treating chronic facet-mediated low back pain. It is intended for interventional pain management physicians and is approved in Europe and has US De Novo marketing authorization.

2 investors

Future Fertility develops an artificial intelligence tool to assess egg quality for fertility treatment using machine learning analysis of oocyte health. The company serves reproductive endocrinologists, embryologists, and patients undergoing IVF procedures.

2 investors

Gale enables e-commerce businesses to accept HSA and FSA card payments and identify eligible products through an IRS-compliant inventory system. The platform targets online retailers selling health and wellness products, helping them reach approximately 80 million HSA/FSA shoppers.

2 investors

GalenusCare (ChorusRx) provides precision pharmacy services for PACE and hospice care programs, combining clinical pharmacists with AI-powered analytics to optimize medication regimens, reduce adverse drug events, and lower medical costs. Its services include medication regimen optimization, precision compliance packaging, symptom kits, and collaborative pharmacy management with value-based care agreements.

2 investors

Galera Therapeutics is a biotechnology company developing antibody-based and other therapeutics. This page profiles Dr. Nancy Chang, a member of the company's Board of Directors.

2 investors

Ganance makes The Heir, a device that clips to existing watches using microsuction technology to collect health data without sacrificing style or requiring a smartwatch. The product serves watch enthusiasts and health-conscious consumers who want to track their wellness data without compromising their preferred timepiece.

2 investors

Gateway Health recruits and helps international nurses immigrate to the United States, handling immigration and visa filings such as EB-3, TN, H-1B and related visas. It works with nurses from the Philippines, African countries, the Middle East, the Caribbean, the UK and Canada, and supports their cultural and clinical adjustment to life in the US.

2 investors

GelSana Therapeutics develops zwitterionic polymer-based biomaterials for wound care, addressing excess sustained inflammation that impedes healing. Its first product, CleraFlex, is a shelf-stable wound dressing designed to reduce inflammation, repel bacteria, balance moisture, and provide a protective barrier.

2 investors

Gencove provides direct-to-consumer genetic sequencing and polygenic risk scoring for health insights. The service analyzes DNA samples to deliver personalized health recommendations across core health areas, ancestry information, and integrates with labs, wearables, and lifestyle data.

2 investors

Gene S is an Australian biotechnology company providing Next Generation Sequencing solutions and gene testing software to laboratories and healthcare providers for delivering pharmacogenomic results.

2 investors

General Medicine connects patients with clinicians and local specialists to address individual healthcare needs. The company provides personalized healthcare coordination services.

2 investors

GenFleet is a biopharmaceutical company developing novel drug therapies focused on RAS targeting and antibody-drug conjugates (ADCs) to address unmet clinical needs in cancer and other serious diseases.

2 investors

Genknowme provides epigenetic blood tests that measure biological age and stress overload to guide individuals and healthcare professionals toward healthier aging and better stress management. The company's tests assess how lifestyle and environmental factors influence DNA methylation patterns and aging processes.

2 investors